• 专利标题:   Screening sulfamethazine nucleic acid aptamers by using graphene oxide-systematic evolution of ligands by exponential enrichment and performing sequence optimization to obtain core recognition region of aptamer.
  • 专利号:   CN111662900-A
  • 发明人:   YUE T, KOU Q, SUN Q, WU P
  • 专利权人:   UNIV CHONGQING NORMAL
  • 国际专利分类:   C12N015/10, C12N015/115, G01N021/64, G01N033/53
  • 专利详细信息:   CN111662900-A 15 Sep 2020 C12N-015/10 202084 Pages: 12 Chinese
  • 申请详细信息:   CN111662900-A CN10401091 13 May 2020
  • 优先权号:   CN10401091

▎ 摘  要

NOVELTY - Method for screening sulfamethazine nucleic acid aptamers involves (a) using non-fixed graphene oxide (GO)-systematic evolution of ligands by exponential enrichment (SELEX) technology to screen sulfamethazine aptamers, and (b) performing sequence optimization to obtain the core recognition region of the aptamer, which is cloned and synthesized in vitro to prepare a nucleic acid aptamer with high affinity and specificity for sulfamethazine. USE - The method is useful for screening sulfamethazine nucleic acid aptamers. The kit is useful for detecting sulfamethazine fluorescence and performing quantitative detection of sulfamethazine in milk test samples or egg tissue test samples (all claimed). DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for kit, which comprises graphene oxide-based fluorescence aptamer sensor comprising FAM (RTM: 5-Carboxyfluorescein)fluorophore-labeled aptamers and graphene oxide, where the FAM (RTM: 5-Carboxyfluorescein)fluorescent group-labeled sulfamethazine nucleic acid aptamer comprises one of 6 (80) base pair sequences (SEQ ID NOs: 1-6) all fully defined in the specification, or a base pair sequence of SEQ ID NO: 1s or 5s. cgttagacg (SEQ ID NO: 1s) and gctgatagc (SEQ ID NO: 5s).